Multiple COVID-19 Vaccine Doses Improve Immune Responses With Progressive and High Seroconversion in Patients With CLL and MBL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
Blood 2022 Oct 07;[EPub Ahead of Print], Y Shen, JA Freeman, J Holland, K Naidu, A Solterbeck, N Van Bilsen, P Downe, I Kerridge, LL Wallman, A Akerman, A Aggarwal, V Milogiannakis, G Martins Costa Gomes, CM Doyle, KJ Sandgren, S Turville, AL Cunningham, SP MulliganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.